ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

10,678.00
-64.00 (-0.60%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -64.00 -0.60% 10,678.00 10,688.00 10,690.00 10,780.00 10,674.00 10,756.00 1,773,970 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 27.83 165.72B

Hutchison China, AstraZeneca Say Drug Shows Potential to Treat Lung Cancer

17/10/2017 10:23am

Dow Jones News


Astrazeneca (LSE:AZN)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Astrazeneca Charts.

By Carlo Martuscelli

 

Hutchison China MediTech Ltd. (HCM.LN) and AstraZeneca PLC (AZN.LN) said jointly Tuesday that the drug savolitinib administered in conjunction with other drugs showed preliminary antitumor activity based on preliminary results of two clinical trials.

China MediTech discovered savolitinib and is developing the drug in cooperation with AstraZeneca. The two studies examined how the drug interacts with osimertinib and gefitinib--drugs trademarked by AstraZeneca--in the treatment of lung cancer.

More specifically, the studies observed how the drugs interacted with patients' epidermal growth factor receptor mutation-positive non-small cell lung cancer.

The results were presented at the World Conference on Lung Cancer in Yokohama, Japan.

 

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com

 

(END) Dow Jones Newswires

October 17, 2017 05:08 ET (09:08 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock